2026 NPPES data Medical Oncology Physician NPI 1134233224 M.D.
Verify on CMS →

James Abbruzzese, M.D.

Medical Oncology Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,792 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
383
Medicare Part D claims · 66 beneficiaries · Medical Oncology Physician avg: 689
Industry payments
$61.15
3 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

James Abbruzzese, M.D. filed 383 Medicare Part D claims in 2023 as a Medical Oncology Physician in Houston, Texas.

383
Part D claims, 2023
$61.15
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

James Abbruzzese, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

383 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

James Abbruzzese, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about James Abbruzzese, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/18/2006

NPI 1134233224

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

383 44% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Texas

How Medical Oncology Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Medical Oncology Physician - 0.1%Medical Oncology Physician0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

James Abbruzzese, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 1515 HOLCOMBE BLVD, Houston, TX, 77030, with a listed phone of (713) 792-6161. NPI 1134233224 was issued on 08/18/2006.

Medicare Part D records for calendar year 2023 show 383 prescription claims written by this provider, covering 66 Medicare beneficiaries and totaling roughly $51K in drug spend, with an opioid prescribing rate of 10.2%.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1515 HOLCOMBE BLVD
Houston, TX 77030

Provider Details

NPI 1134233224
Specialty Medical Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 08/18/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for James Abbruzzese, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$61

Largest payer

Baxter Healthcare

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to James Abbruzzese, M.D.. To verify James Abbruzzese, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

383
Total Claims
$51K
Total Drug Cost
66
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
419
Total Day Supply
9,763
Generic Drug Cost
$7K
Opioid Claims
39 (10.2% rate)

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.82
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What James Abbruzzese, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ondansetron Hcl
72
Prochlorperazine Maleate
62
Dexamethasone
26
Eliquis
Apixaban
25
Oxycodone Hcl
22
Lidocaine-Prilocaine
Lidocaine/Prilocaine
15
Pantoprazole Sodium
15
Olanzapine
14
Tramadol Hcl
14
Klor-Con M20
Potassium Chloride
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How James Abbruzzese, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

James Abbruzzese, M.D.'s 383 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Abbruzzese.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is James Abbruzzese, M.D.'s specialty?
James Abbruzzese, M.D. specializes in Medical Oncology Physician and practices in Houston, Texas. Credentials: M.D..
How much does James Abbruzzese, M.D. prescribe under Medicare Part D?
In 2023, James Abbruzzese, M.D. wrote 383 Medicare Part D claims totaling $51K in drug costs for 66 beneficiaries.
Where is James Abbruzzese, M.D. located?
James Abbruzzese, M.D. is located at 1515 HOLCOMBE BLVD, Houston, TX, 77030. Phone: (713) 792-6161.
What is James Abbruzzese, M.D.'s NPI number?
James Abbruzzese, M.D.'s National Provider Identifier (NPI) is 1134233224, issued on 08/18/2006.
Does James Abbruzzese, M.D. prescribe opioids?
Yes, James Abbruzzese, M.D. had 39 opioid claims in 2023 with an opioid prescribing rate of 10.2%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does James Abbruzzese, M.D. prescribe most often?
Based on 2023 Medicare Part D data, James Abbruzzese, M.D.'s most frequently prescribed drugs include Ondansetron Hcl, Prochlorperazine Maleate, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does James Abbruzzese, M.D. accept Medicare?
James Abbruzzese, M.D. appears in CMS Medicare data with 383 Part D claims and 66 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify James Abbruzzese, M.D.'s credentials?
James Abbruzzese, M.D.'s NPI is 1134233224 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.